Images List Premium Download Classic

Analogue

Analogue-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Hepcidin analogues and uses thereof
Protagonist Therapeutics, Inc.
April 12, 2018 - N°20180100004

The present invention relates, inter alia, to certain hepcidin peptide analogues, including peptides and dimers thereof, and to the use of the peptides and peptide dimers in the treatment and/or prevention of a variety of diseases, conditions or disorders, including treatment and/or prevention of iron overload diseases, which include hereditary hemochromatosis and iron-loading anemias, and other conditions and ...
Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis
Brookhaven Science Associates, Llc
April 12, 2018 - N°20180100002

A composition comprising a synthetic growth factor analogue comprising a non-growth factor heparin binding region, a linker and a sequence that binds specifically to a cell surface receptor and an osteoconductive material where the synthetic growth factor analogue is attached to and can be released from the osteoconductive material and is an amplifier/co-activator of osteoinduction.
Analogue Patent Pack
Download 338+ patent application PDFs
Analogue Patent Applications
Download 338+ Analogue-related PDFs
For professional research & prior art discovery
inventor
  • 338+ full patent PDF documents of Analogue-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods of treating iron overload
La Jolla Pharmaceutical Company
April 12, 2018 - N°20180099023

Provided herein are compositions and methods related to the use of hepcidin and/or hepcidin analogues for the treatment and/or prevention of iron overload in a subject (e. G., a human subject) and/or for reducing serum iron levels in a subject without inducing serum iron rebound.
Measuring concentration of analytes in liquid samples using surface-enhanced raman spectroscopy
Ondavia, Inc.
April 05, 2018 - N°20180095062

A hand-held microfluidic testing device is provided that includes a housing having a cartridge receiving port and a cartridge for input to the cartridge receiving port. An optical detection system in the housing is capable of providing an illuminated electric field useful for raman spectroscopy. The cartridge may have a sample well. The sample well is loaded with a mixture ...
Acylated glucagon analogue
Boehringer Ingelheim International Gmbh
April 05, 2018 - N°20180094038

The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel acylated glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the glp-1 receptor as compared to human glucagon.
Analogue Patent Pack
Download 338+ patent application PDFs
Analogue Patent Applications
Download 338+ Analogue-related PDFs
For professional research & prior art discovery
inventor
  • 338+ full patent PDF documents of Analogue-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Oligonucleotide analogues targeting human lmna
Sarepta Therapeutics, Inc.
April 05, 2018 - N°20180092938

Provided are lmna-targeted antisense oligonucleotides for reducing expression of one or more aberrantly spliced lmna mrna isoforms that encode progerin.
A specific trifluoroethyl quinoline analogue for use in the treatment of sjögren's syndrome
Ucb Biopharma Sprl
April 05, 2018 - N°20180092921

N-{(r)-1-[8-chloro-2-(1-oxypyridin-3-yl)-quinolin-3-yl]-2,2,2-trifluoroethyl}-pyrido[3,2-d]pyrimidin-4-ylamine is effective in the treatment and/or prevention of sjögren's syndrome.
Substituted n-([1,1'-biphenyl]-3-yl)-[1,1'-biphenyl]-3-carboxamide analogs as inhibitors for beta-catenin/b-cell ...
University Of Utah Research Foundation
April 05, 2018 - N°20180092866

In one aspect, the invention relates to substituted n-([1,1′-biphenyl]-3-yl)-[1,1′-biphenyl]-3-carboxamide analogues, derivatives thereof, and related compound; synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating disorders, e. G., various tumors and cancers, associated with β-catenin/bcl9 protein-protein interaction dysfunction using the compounds and compositions. ...
Method for controlling digital-to-analogue converters and rf transmit circuit arrangement
Rohde & Schwarz Gmbh & Co. Kg
March 29, 2018 - N°20180091203

The invention relates to a method for controlling digital-to-analogue converters (dac), the method comprising: providing a plurality of digital-to-analogue converters (dac) of a multi-channel converter array wherein each dac includes a separate clock generator; generating, by each clock generator, a rf carrier signal; converting, by each dac, digital data signals into analogue rf data signals based on the carrier signals ...
A composition comprising prostacyclin andor analogues thereof for treatment of acute critically ill patients
Rigshospitalet
March 29, 2018 - N°20180088131

Use of prostacyclin or an analogue thereof for treatment of a new medical indication in acute critically ill patients, in particular acute critically ill patients with systemic endothelial damage, a biomarker for identifying individuals that have a new medical indication, and a method for identifying a new medical indication.
Methods and compositions for labeling nucleic acids
President And Fellows Of Harvard College
March 29, 2018 - N°20180087091

The present invention relates to methods for the labeling of nucleic acid polymers in vitro and in vivo. In particular, the methods include a [3+2] cycloaddition between a nucleotide analogue incorporated into a nucleic acid polymer and a reagent attached to a label. Such methods do not require fixation and denaturation and therefore can be applied to the labeling of nucleic ...
Hepcidin analogues and uses thereof
Protagonist Therapeutics, Inc.
March 29, 2018 - N°20180086811

The present invention relates, inter alia, to certain hepcidin peptide analogues, including peptides and dimers thereof, and to the use of the peptides and peptide dimers in the treatment and/or prevention of a variety of diseases, conditions or disorders, including treatment and/or prevention of iron overload diseases, which include hereditary hemochromatosis and iron-loading anemias, and other conditions and ...
Analogue Patent Pack
Download 338+ patent application PDFs
Analogue Patent Applications
Download 338+ Analogue-related PDFs
For professional research & prior art discovery
inventor
  • 338+ full patent PDF documents of Analogue-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Controlled release pharmaceutical formulations of nitozoxanide
Romark Laboratories L.c.
March 29, 2018 - N°20180085353

Solid dosage formulations of nitazoxanide or a nitazoxanide analogue are provided that comprise a controlled release portion and an immediate release portion. The pharmaceutical composition is typically in the form of a bilayer solid oral dosage form comprising (a) a first layer comprising a first quantity of nitazoxanide or analogue thereof in a controlled release formulation; and (b) a second ...
Targeted liposomal delivery of cgmp analogues
Mireca Medicines Gmbh
March 29, 2018 - N°20180085311

The invention relates to means and methods of targeted drug delivery of therapeutic agent to and across the blood-ocular barrier. In particular, the invention relates to cyclic guanosine-3′,5 ‘-monophosphate analogues as therapeutic agent for treating retinal diseases. The cgmpss targeted to the blood-ocular barrier by glutathione-based ligands that facilitate the specific binding to and enhanced internalization by glutathione ...
Apparatus removing self-interference in environment supporting fdr method
Lg Electronics Inc.
March 22, 2018 - N°20180083717

An apparatus for removing self-interference in an environment supporting an fdr method according to the present invention may comprise: an analogue self-interference removal unit that is constructed to remove a first analogue self-interference by subtracting a self-interference signal received through a first delay circuit connected between an rf transmission chain and an rf reception chain of the apparatus from a ...
Electronic timepiece with two analogue type hands
Eta Sa Manufacture Horlogere Suisse
March 22, 2018 - N°20180081323

The present invention concerns an electronic timepiece with two analogue type hands. The timepiece includes an hour hand and a minute hand, the hour hand and the minute hand being arranged to operate independently of each other. The hour hand and the minute hand are arranged to operate in a first operating mode and in a second operating mode, which ...
Gnrh analogue formulations
March 22, 2018 - N°20180078647

Wherein the pre-formulation forms, or is capable of forming, at least one liquid crystalline phase structure upon contact with an aqueous fluid. The invention further relates to methods of treatment comprising administration of such compositions, pre-filled administration devices and kits containing the formulations.
Novel formulations
Arecor Limited
March 22, 2018 - N°20180078645

According to the invention there is provided inter alia an aqueous liquid pharmaceutical formulation comprising insulin or an insulin analogue, ionic zinc, a chelating agent and polysorbate 80.
Improvements relating to monopulse radar apparatus
Mbda Uk Limited
March 15, 2018 - N°20180074183

Monopulse radar apparatus is disclosed. The apparatus comprises a digital processor and an antenna having a plurality of receive channels through which signals received by the antenna are passed to the processor. Each receive channel includes an analogue to digital converter, and the processor is arranged to calculate sum and difference signals from the signals received through each receive channel. ...
Nucleic acid sequencing by nanopore detection of tag molecules
Genia Technologies, Inc.
March 15, 2018 - N°20180073071

This disclosure provides systems and methods for sequencing nucleic acids using nucleotide analogues and translocation of tags from incorporated nucleotide analogues through a nanopore. In aspects, this disclosure is related to compositions, methods, and systems for sequencing nucleic acids using tag molecules and detection of translocation through a nanopore of tags released from incorporation of the molecule.
Loading